# Dulaglutide (Trulicity)

Source: https://aminodesk.com/library/dulaglutide
Publisher: Amino Desk
Updated: 2026-11-17
Clinical review: pending

Dulaglutide is the weekly GLP-1 injection sold as Trulicity. It is approved for type 2 diabetes and is not approved for weight loss. People on it do lose some weight, but far less than on the drugs built for that purpose.

- **Legal lane:** FDA-approved for type 2 diabetes, prescription only. Not approved for weight loss.
- **Evidence grade:** A for its approved use
- **Form:** weekly injection under the skin, from a single-dose pen
- **Brand:** Trulicity

## What it is

Dulaglutide is a GLP-1 medication first approved in the US in 2014. It belongs to the same family as [semaglutide](https://aminodesk.com/library/semaglutide) and [liraglutide](https://aminodesk.com/library/liraglutide). It is prescribed to improve blood sugar in type 2 diabetes, and its label also covers lowering the risk of major heart events in adults with type 2 diabetes who have heart disease or several risk factors.

## What the evidence shows

Its trials were diabetes trials. Weight was a secondary measure.

In the trial that tested the higher doses, AWARD-11, 1,842 adults with type 2 diabetes took 1.5 mg, 3 mg or 4.5 mg a week. At 36 weeks, average weight change was about 6.6 lb on 1.5 mg, 8.4 lb on 3 mg and 10.1 lb on 4.5 mg, from a starting weight near 210 lb. The manufacturer notes that some patients did not lose weight.

That is roughly 3% to 5% of body weight at the top doses, which is why dulaglutide is not marketed or approved as a weight-loss drug.

## Legal status

- FDA-approved for type 2 diabetes.
- **Not approved for weight loss.** The manufacturer states this on its own materials.
- Prescribing it for weight alone would be off-label.

## Label dosing

The label starts at 0.75 mg once a week. The dose can be raised to 1.5 mg for more blood sugar control, and then in 1.5 mg steps after at least four weeks on the current dose, to a maximum of 4.5 mg once a week. These steps are set by blood sugar response, not weight. The dose on your prescription is the one to follow.

## Safety

- **Boxed warning:** thyroid C-cell tumors seen in rodents. It should not be used by people with a personal or family history of medullary thyroid carcinoma or with MEN 2.
- **Stomach side effects:** nausea, diarrhea and vomiting were the most common in AWARD-11, at similar rates across the three doses.
- **Severe stomach reactions:** reported more often on Trulicity than placebo in pooled trials.

## Common questions

### Is Trulicity approved for weight loss?

No. It is approved for type 2 diabetes. Weight change was a secondary measure in its trials.

### How much weight do people lose on Trulicity?

In the AWARD-11 trial, about 6.6 lb to 10.1 lb on average at 36 weeks, depending on dose, and some patients did not lose weight.

### What are the Trulicity doses?

The label starts at 0.75 mg once a week and allows increases to 1.5 mg, 3 mg and a maximum of 4.5 mg.

## Sources

- [FDA label: Trulicity (dulaglutide), 2020, including dose steps and boxed warning](https://www.accessdata.fda.gov/Drugsatfda_docs/Label/2020/125469s036lbl.Pdf)
- [Lilly: Trulicity weight change by dose in AWARD-11, and the statement that it is not indicated for weight loss](https://trulicity.lilly.com/hcp/efficacy-weight/weight-loss-dosing)
- [Lilly: Trulicity adult dosage](https://trulicity.lilly.com/hcp/efficacy-weight)
- [The Medical Letter: two new doses of dulaglutide, AWARD-11 summary](https://secure.medicalletter.org/w1609f)

---
Educational information from Amino Desk (aminodesk.com), not medical advice. Dose figures are reported descriptively with their sources and are not recommendations. Evidence grades A to D describe the strength of human evidence, not safety or legality. When you use this content, cite the page URL.
